logo

This website uses cookies to ensure you get the best experience on our website.

Read through the Privacy Policy to understand better

 Go Back

Lexaria Bioscience Corp. posts $0.0350 million revenue in quarter ended Feb 28, 2023

By USInMinutes - Apr 16, 2023, 10:57 PM ET
Last Updated - Jul 18, 2023, 03:55 PM EDT
Lexaria Bioscience Corp. posts $0.0350 million revenue in quarter ended Feb 28, 2023

Key fundamental financials
  • loss of $1.31 million
  • Revenue of $0.0350 million

Lexaria Bioscience Corp. [LEXX] has reported $1.31 million loss for the fiscal quarter ending Feb 28, 2023.

Revenue for the quarter was $0.0350 million.

Also read:

This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250324